20 June 2013
Keywords: fda, approves, novartis, gleevec, gist, food, drug
Article | 12 January 2009
The US Food and Drug Administration has extended the indication of Swiss drug major Novartis' Gleevec (imatinib mesylate) to include ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
19 June 2013
© 2013 thepharmaletter.com